Edition:
India

Concert Pharmaceuticals Initiates Enrollment In Second Cohort Of CTP-543 Trial


Monday, 12 Feb 2018 

Feb 12 (Reuters) - Concert Pharmaceuticals Inc ::CONCERT PHARMACEUTICALS ANNOUNCES INITIATION OF ENROLLMENT IN SECOND COHORT OF CTP-543 PHASE 2A TRIAL FOR ALOPECIA AREATA.CONCERT PHARMACEUTICALS INC - PHASE 2A TRIAL ON TRACK TO COMPLETE IN SECOND HALF OF 2018. 

Company Quote

7.82
-0.06 -0.76%
1:11am IST